159 related articles for article (PubMed ID: 23611223)
1. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].
Wu RJ; Huang YQ; Ma XD
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of an imatinib resistant cell line K562/G01 and its characterization].
Qi J; Peng H; Gu ZL; Liang ZQ; Yang CZ
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):337-41. PubMed ID: 15308010
[TBL] [Abstract][Full Text] [Related]
3. [Triptolide inhibits proliferation and induces apoptosis of imatinib resistant K562/G01 cells].
Wen SQ; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1148-52. PubMed ID: 24156423
[TBL] [Abstract][Full Text] [Related]
4. [Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].
Li BJ; Liu TB; Wang WF; Lin MH; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):1-7. PubMed ID: 26913384
[TBL] [Abstract][Full Text] [Related]
5. Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro.
Wu LX; Wu Y; Chen RJ; Liu Y; Huang LS; Lou LG; Zheng ZH; Chen YZ; Xu JH
Acta Pharmacol Sin; 2014 Mar; 35(3):401-9. PubMed ID: 24487968
[TBL] [Abstract][Full Text] [Related]
6. [CRISPR/Cas9-mediated microRNA-21 knockout increased imatinib sensitivity in chronic myeloid leukemia cells].
Zhang Y; Wang LY; Li JZ; Jiang PF; Hu JD; Chen BY
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):243-249. PubMed ID: 33910311
[No Abstract] [Full Text] [Related]
7. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ
Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456
[TBL] [Abstract][Full Text] [Related]
8. Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein.
Xu HB; Xu LZ; Mao XP; Fu J
Phytomedicine; 2014 Jun; 21(7):1004-9. PubMed ID: 24680616
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].
Shi DX; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
11. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
12. [Study on the mechanisms of imatinib-resistance of cancer stem-like cells in K562/Vp16 cell line].
Song YP; Fang BJ; Wei XD; Zheng S
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):669-73. PubMed ID: 16620554
[TBL] [Abstract][Full Text] [Related]
13. Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.
Scappini B; Gatto S; Onida F; Ricci C; Divoky V; Wierda WG; Andreeff M; Dong L; Hayes K; Verstovsek S; Kantarjian HM; Beran M
Cancer; 2004 Apr; 100(7):1459-71. PubMed ID: 15042680
[TBL] [Abstract][Full Text] [Related]
14. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
16. [Suppression of NAMPT expression enhances the sensitivity of K562 cells to imatinib and its relative mechanism].
Lin PP; Bai XJ; Yue ZX; Yan SF; Li ZW; Gao C; Mei YY; Wang KL; Li WJ; Ding W; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):235-41. PubMed ID: 22541073
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway.
Kurosu T; Wu N; Oshikawa G; Kagechika H; Miura O
Apoptosis; 2010 May; 15(5):608-20. PubMed ID: 20094798
[TBL] [Abstract][Full Text] [Related]
18. Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells.
Chen Y; Hu D
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):41-4. PubMed ID: 15165112
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Recombinant Adenovirus AdE-SH2-Caspase 8 on the Apoptosis of Imatinib-resistant K562/G01 Cell Line].
Wang L; Fei C; Huang ZL; Li H; Liu ZL; Feng WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):976-81. PubMed ID: 26314429
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo].
Zhang YF; Xu GB; Gan YC; Xu XH; Xu RZ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1997-2001. PubMed ID: 22200699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]